OpenBilldrug price receipt

NADAC week of 2026-10-14

RIVASTIGMINE 1.5 MG CAPSULE

For 30 capsules

Pharmacies pay

$4.93 filed

30 × $0.16428 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$10.67 estimated

$4.93 + $0.74 (15%) + $5.00 fee per fill = $10.67

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

RIVASTIGMINE 1.5 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as rivastigmine tartrate.

FDA gives its dosage form as capsule and its route as oral.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Macleods Pharmaceuticals Limited and Dr. Reddy's Laboratories Limited.

FDA’s Established Pharmacologic Class for it is Cholinesterase Inhibitor.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 10 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.93 for 30 capsules (30 × $0.16428 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 8 labelers

LabelerNDCsPharmacies pay per unit
Dr. Reddy's Laboratories Limited2$0.16428 per EA filed
Macleods Pharmaceuticals Limited2$0.16428 per EA filed
Alembic Pharmaceuticals Inc.1$0.16428 per EA filed
American Health Packaging1$0.16428 per EA filed
Aurobindo Pharma Limited1$0.16428 per EA filed
Chartwell RX, LLC1$0.16428 per EA filed
Major Pharmaceuticals1$0.16428 per EA filed
Modavar Pharmaceuticals LLC1$0.16428 per EA filed
Not listed as a package in the FDA directory1$0.16428 per EA filed
All 11 NDCs, with labeler and price
  • 00904-7107-61 · Major Pharmaceuticals · $0.16428 per EA · eff. 2026-09-23 filed
  • 33342-0089-09 · Macleods Pharmaceuticals Limited · $0.16428 per EA · eff. 2026-09-23 filed
  • 33342-0089-15 · Macleods Pharmaceuticals Limited · $0.16428 per EA · eff. 2026-09-23 filed
  • 55111-0352-05 · Dr. Reddy's Laboratories Limited · $0.16428 per EA · eff. 2026-09-23 filed
  • 55111-0352-60 · Dr. Reddy's Laboratories Limited · $0.16428 per EA · eff. 2026-09-23 filed
  • 60687-0777-01 · American Health Packaging · $0.16428 per EA · eff. 2026-09-23 filed
  • 60687-0777-11 · not listed as a package in the FDA directory · $0.16428 per EA · eff. 2026-09-23 filed
  • 62135-0900-60 · Chartwell RX, LLC · $0.16428 per EA · eff. 2026-09-23 filed
  • 62332-0063-60 · Alembic Pharmaceuticals Inc. · $0.16428 per EA · eff. 2026-09-23 filed
  • 65862-0648-60 · Aurobindo Pharma Limited · $0.16428 per EA · eff. 2026-09-23 filed
  • 72241-0011-03 · Modavar Pharmaceuticals LLC · $0.16428 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name rivastigmine tartrate with RIVASTIGMINE 1.5 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
RIVASTIGMINE 1.5 MG CAPSULE this page
generic · capsule
$0.16428 per EA filed
eff. 2026-09-23
We don’t know yet
RIVASTIGMINE 3 MG CAPSULE
generic · capsule
$0.14581 per EA filed
eff. 2026-09-23
We don’t know yet
RIVASTIGMINE 4.5 MG CAPSULE
generic · capsule
$0.17435 per EA filed
eff. 2026-09-23
We don’t know yet
RIVASTIGMINE 6 MG CAPSULE
generic · capsule
$0.15637 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $0.16428 per EA filed.

Of the 28 other products in FDA’s Cholinesterase Inhibitor class priced per EA, 24 have a higher middle NADAC price and 4 a lower one. The one in the middle is GALANTAMINE ER 16 MG CAPSULE, at $0.846 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.